Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
2 other identifiers
interventional
200
1 country
2
Brief Summary
The purpose of this study is to determine whether a 14 week intervention is successful in improving outcomes for women with gestational diabetes mellitus and their infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2012
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 10, 2013
CompletedFirst Posted
Study publicly available on registry
March 12, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedJune 13, 2024
June 1, 2015
2.2 years
March 10, 2013
June 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
fasting blood glucose
Change in fasting blood glucose in mothers
Baseline to 10 months postpartum
weight (body mass index)
Change in weight (body mass index)in mothers
Baseline to 10 months postpartum
Secondary Outcomes (11)
oral glucose tolerance test
Baseline to 10 months postpartum
insulin levels
Baseline to 10 months postpartum
homeostasis model assessment
Baseline to 10 months postpartum
hemoglobin A1c
Baseline to 10 months postpartum
complete lipid panel
Baseline to 10 months postpartum
- +6 more secondary outcomes
Study Arms (2)
intervention
EXPERIMENTALBreastfeeding, progression to type 2 diabetes, nutrition, and exercise education, coping skills training, exercise training, a home-based exercise program and educational and motivational text messaging.
Wait-listed control group
NO INTERVENTIONWait-listed control group receive usual care delivered by their health care provider and after completion of their time in the study they are offered the intervention
Interventions
Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy.
Eligibility Criteria
You may qualify if:
- Women between 22-36 weeks of pregnancy who are diagnosed with GDM
- A diagnosis of GDM during the current pregnancy by two or more 100g Oral Glucose Tolerance Test (OGTT) values exceeding established thresholds (fasting 95, 1h 180, 2h 155, 3h 140 mg/dL)
- Age 18-45 years old
- A pre-pregnancy body mass index \> 25kg/m2
- Ability to read and write in English
- Willingness to consent for themselves and their infant
You may not qualify if:
- They have a A1c ≥ 6.5 mg/dL (Type 2 diabetes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UNC-Rex Health Care
Raleigh, North Carolina, 27607, United States
WakeMed
Raleigh, North Carolina, 27610, United States
Related Publications (2)
Stuebe AM, Bonuck K, Adatorwovor R, Schwartz TA, Berry DC. A Cluster Randomized Trial of Tailored Breastfeeding Support for Women with Gestational Diabetes. Breastfeed Med. 2016 Dec;11(10):504-513. doi: 10.1089/bfm.2016.0069. Epub 2016 Oct 26.
PMID: 27782758DERIVEDBerry DC, Neal M, Hall EG, Schwartz TA, Verbiest S, Bonuck K, Goodnight W, Brody S, Dorman KF, Menard MK, Stuebe AM. Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study. BMC Pregnancy Childbirth. 2013 Oct 10;13:184. doi: 10.1186/1471-2393-13-184.
PMID: 24112417DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diane Berry, PhD, ANP-BC
University of North Carolina, Chapel Hill
- PRINCIPAL INVESTIGATOR
Alison Stuebe, MD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2013
First Posted
March 12, 2013
Study Start
May 1, 2012
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
June 13, 2024
Record last verified: 2015-06